News Releases

January 25, 2001

REVISION OF BUSINESS FORECAST FOR THE YEAR ENDING MARCH 31, 2001

Dainippon Pharmaceutical Co., Ltd. revised the business forecast which was announced on November 10, 2000.(Release date : January 25, 2001)

(1)Revision of non-consolidated business results forecast for the year ending March 31, 2001(April 1, 2000 to March 31, 2001)

  Net sales Recurring
income
Net income
Original Forecast (A) 145,000 14,000 7,900
Revised Forecast (B) 146,000 15,500 8,700
Difference (B-A) 1,000 1,500 800
% change 0.7 10.7 10.1
Results for the year ended March 31, 2000 142,435 13,341 6,734

(Unit : Yen million)

(2)Revision of consolidated business results forecast for the year ending March 31, 2001(April 1, 2000 to March 31, 2001)

  Net sales Recurring
income
Net income
Original Forecast (A) 158,000 14,400 8,000
Revised Forecast (B) 159,000 15,900 8,800
Difference (B-A) 1,000 1,500 800
% change 0.6 10.4 10.0
Results for the year ended March 31, 2000 155,496 13,776 6,883

(Unit : Yen million)

(3)Reasons of Revision Recurring income and net income for the year ending March 31, 2001 are expected to exceed the original forecast announced on November 10, 2000, because of improvement of the cost of sales ratio due to the change of product mix.

Dainippon revises the non-consolidated and consolidated original forecast reflecting the above change.

(Reference) Operating Income

  Original Forecast Revised Forecast % change Results for the year ended March 31, 2000
Non-
consolidated
12,500 14,500 16.0% 12,001
Consolidated 13,100 15,100 15.3% 12,686

(Unit : Yen million)